Background: COVID-19, an infectious viral disease, has caused a global health crisis. Most cases remain asymptomatic. The majority of patients have mild symptoms while about 15% develop a severe form. The clinical spectrum of SARS-CoV-2 infection appears broad, encompassing asymptomatic infection, upper respiratory tract symptoms, and severe viral pneumonia with respiratory failure that can lead to death. Laboratory tests play an important role in the management of COVID-19 patients. In addition to being essential for the diagnosis, several biological analyses make it possible to identify the inflammatory processes and the potential complications of this disease. This study attempted to identify biochemical assays that could help in the prognosis of the disease to ensure early management. Methods: This was a descriptive study. It focused on patients hospitalized for COVID-19 from March 19, 2020, to January 26, 2021, at the Infectious Disease Management Centre in Lomé (Togo). Medians were compared using the (Mann-Whitney and Wilcoxon) test and frequencies were compared using the Chi-square test or Fisher’s exact test. Results: We included 782 patients. The median age was 41 years IQR from 32 to 55. We observed several biochemical abnormalities in varying proportions for all biochemical parameters studied. Compared to non-serious patients, critically ill patients at admission had more frequently elevated urea, creatinine, transaminases, TG, GGT, CRP and blood glucose. Also, they had more frequent decreases in total cholesterol, HDL-c, blood chloride, and blood calcium. As for patients who died during hospitalization, compared with healed patients, they had more frequent elevations of urea, creatinine, AST, ALT, GGT. CRP and blood glucose. They also had a more frequent decrease in total cholesterol, HDL-c, blood chloride, blood calcium, and blood glucose (p = 0.025). Conclusion: This study shows that COVID-19 is a multi-organ systemic inflammatory viral disease that should be systematically investigated once the diagnosis is confirmed.
References
[1]
COVID-19—Chronologie de l’action de l’OMS. https://www.who.int/fr/news/item/27-04-2020-who-timeline---covid-19
[2]
WHO Coronavirus (COVID-19) Dashboard. WHO Coronavirus (COVID-19) Dashboard with Vaccination Data. https://covid19.who.int/
[3]
Epidémie à Coronavirus, COVID-19, Le Togo déclare un premier cas confirmé. OMS, Bureau régional pour l’Afrique. https://www.afro.who.int/fr/news/epidemie-coronavirus-covid-19-le-togo-declare-un-premier-cas-confirme
[4]
République togolaise. Situation au Togo. COVID 19—Google Search. https://covid19.gouv.tg/situation-au-togo/
[5]
Zhou, F., Yu, T., Du, R., Fan, G., Liu, Y., Liu, Z., et al. (2020) Clinical Course and Risk Factors for Mortality of Adult Inpatients with COVID-19 in Wuhan, China: A Retrospective Cohort Study. Lancet, 395, 1054-1062. https://doi.org/10.1016/S0140-6736(20)30566-3
[6]
Bonny, V., Maillard, A., Mousseaux, C., Plaçais, L. and Richier, Q. (2020) COVID-19: Pathogenesis of a Multi-Faceted Disease. La Revue de Médecine Interne, 41, 375-389. https://doi.org/10.1016/j.revmed.2020.05.003
[7]
Ponti, G., Maccaferri, M., Ruini, C., Tomasi, A. and Ozben, T. (2020) Biomarkers Associated with COVID-19 Disease Progression. Critical Reviews in Clinical Laboratory Sciences, 57, 389-399. https://doi.org/10.1080/10408363.2020.1770685
[8]
An, P.-J., Zhu, Y.Z. and Yang, L.-P. (2020) Biochemical Indicators of Coronavirus Disease 2019 Exacerbation and the Clinical Implications. Pharmacological Research, 159, Article ID: 104946. https://doi.org/10.1016/j.phrs.2020.104946
[9]
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., et al. (2020) Clinical Features of Patients Infected with 2019 Novel Coronavirus in Wuhan, China. Lancet, 395, 497-506. https://doi.org/10.1016/S0140-6736(20)30183-5
[10]
Lippi, G., South, A.M. and Henry, B.M. (2020) Electrolyte Imbalances in Patients with Severe Coronavirus Disease 2019 (COVID-19). Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 57, 262-265. https://doi.org/10.1177/0004563220922255
[11]
Ghahramani, S., Tabrizi, R., Lankarani, K.B., Kashani, S.M.A., Rezaei, S., Zeidi, N., et al. (2020) Laboratory Features of Severe vs. Non-Severe COVID-19 Patients in Asian Populations: A Systematic Review and Meta-Analysis. European Journal of Medical Research, 25, Article No. 30. https://doi.org/10.1186/s40001-020-00432-3
[12]
Lippi, G. and Plebani, M. (2020) The Critical Role of Laboratory Medicine during Coronavirus Disease 2019 (COVID-19) and Other Viral Outbreaks. Clinical Chemistry and Laboratory Medicine, 58, 1063-1069. https://doi.org/10.1515/cclm-2020-0240
[13]
Klauke, R., Schmidt, E. and Lorentz, K. (1993) Recommendations for Carrying out Standard ECCLS Procedures (1988) for the Catalytic Concentrations of Creatine Kinase, Aspartate Aminotransferase, Alanine Aminotransferase and Gamma-Glutamyltransferase at 37 Degrees C. Standardization Committee of the German Society for Clinical Chemistry, Enzyme Working Group of the German Society for Clinical Chemistry. European Journal of Clinical Chemistry and Clinical Biochemistry, 31, 901-909. https://pubmed.ncbi.nlm.nih.gov/7907890/
[14]
WHO (2020) Clinical Management of Severe Acute Respiratory Infection When Novel Coronavirus (2019-nCoV) Infection Is Suspected: Interim Guidance. 28 January 2020. https://iris.who.int/handle/10665/330893
[15]
Menon, R., Otto, E.A., Sealfon, R., Nair, V., Wong, A.K., Theesfeld, C.L., et al. (2020) SARS-CoV-2 Receptor Networks in Diabetic and COVID-19-Associated Kidney Disease. Kidney International, 98, 1502-1518. https://doi.org/10.1016/j.kint.2020.09.015
[16]
Funderburg, N.T. and Mehta, N.N. (2016) Lipid Abnormalities and Inflammation in HIV Inflection. Current HIV/AIDS Reports, 13, 218-225. https://doi.org/10.1007/s11904-016-0321-0
[17]
Sun, J., Aghemo, A., Forner, A. and Valenti, L. (2020) COVID-19 and Liver Disease. Liver International, 40, 1278-1281. https://doi.org/10.1111/liv.14470
[18]
Aziz, M., Fatima, R., Lee-Smith, W. and Assaly, R. (2020) The Association of Low Serum Albumin Level with Severe COVID-19: A Systematic Review and Meta-Analysis. Critical Care, 24, Article No. 255. https://doi.org/10.1186/s13054-020-02995-3
[19]
Yousaf, Z., Al-Shokri, S.D., Al-Soub, H. and Mohamed, M.F.H. (2020) COVID-19-Associated SIADH: A Clue in the Times of Pandemic! American Journal of Physiology-Endocrinology and Metabolism, 318, E882-E885. https://doi.org/10.1152/ajpendo.00178.2020
[20]
Harrison, M. (2015) Erythrocyte Sedimentation Rate and C-Reactive Protein. Australian Prescriber, 38, 93-94. https://doi.org/10.18773/austprescr.2015.034
[21]
Sadio, A.J., Gbeasor-Komlanvi, F.A., Konu, R.Y., Bakoubayi, A.W., Tchankoni, M.K., Bitty-Anderson, A.M., Gomez, I.M., Denadou, C.P., Anani, J., Kouanfack, H.R., Kpeto, I.K., Salou, M. and Ekouevi, D.K. (2021) Assessment of Self-Medication Practices in the Context of the COVID-19 Outbreak in Togo. BMC Public Health, 21, Article No. 58. https://doi.org/10.1186/s12889-020-10145-1
[22]
Ketfi, A., Chabati, O., Chemali, S., Mahjoub, M., Gharnaout, M., Touahri, R., et al. (2020) Profil clinique, Biologique et radiologique des patients Algériens hospitalisés pour COVID-19: Données préliminaires. Pan African Medical Journal, 35, Article 77. https://doi.org/10.11604/pamj.supp.2020.35.2.23807
[23]
Cheng, Y., Luo, R., Wang, K., Zhang, M., Wang, Z., Dong, L., et al. (2020) Kidney Disease Is Associated with In-Hospital Death of Patients with COVID-19. Kidney International, 97, 829-838. https://doi.org/10.1016/j.kint.2020.03.005
[24]
Chen, T., Wu, D., Chen, H., Yan, W., Yang, D., Chen, G., et al. (2020) Clinical Characteristics of 113 Deceased Patients with Coronavirus Disease 2019: Retrospective Study. BMJ, 368, Article No. m1091. https://doi.org/10.1136/bmj.m1091
[25]
Chen, N., Zhou, M., Dong, X., Qu, J., Gong, F., Han, Y., et al. (2020) Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study. Lancet, 395, 507-513. https://doi.org/10.1016/S0140-6736(20)30211-7
[26]
Li, X., Xu, S., Yu, M., Wang, K., Tao, Y., Zhou, Y., et al. (2020) Risk Factors for Severity and Mortality in Adult COVID-19 Inpatients in Wuhan. Journal of Allergy and Clinical Immunology, 146, 110-118. https://doi.org/10.1016/j.jaci.2020.04.006
[27]
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., et al. (2020) Clinical Characteristics of Coronavirus Disease 2019 in China. New England Journal of Medicine, 382, 1708-1720. https://doi.org/10.1056/NEJMoa2002032
[28]
El Aidaoui, K., Haoudar, A., Khalis, M., Kantri, A., Ziati, J., El Ghanmi, A., et al. (2020) Predictors of Severity in Covid-19 Patients in Casablanca, Morocco. Cureus, 12, e10716. https://doi.org/10.7759/cureus.10716
[29]
Wei, X., Zeng, W., Su, J., Wan, H., Yu, X., Cao, X., et al. (2020) Hypolipidemia Is Associated with the Severity of COVID-19. Journal of Clinical Lipidology, 14, 297-304. https://doi.org/10.1016/j.jacl.2020.04.008
Masana, L., Correig, E., Ibarretxe, D., Anoro, E., Arroyo, J.A., Jericó, C., et al. (2021) Low HDL and High Triglycerides Predict COVID-19 Severity. Scientific Reports, 11, Article No. 7217.
[32]
Tezcan, M.E., Dogan Gokce, G., Sen, N., Zorlutuna Kaymak, N. and Ozer, R.S. (2020) Baseline Electrolyte Abnormalities Would Be Related to Poor Prognosis in Hospitalized Coronavirus Disease 2019 Patients. New Microbes and New Infections, 37, Article ID: 100753. https://doi.org/10.1016/j.nmni.2020.100753
[33]
Yu, C., Lei, Q., Li, W., Wang, X., Li, W. and Liu, W. (2020) Epidemiological and Clinical Characteristics of 1663 Hospitalized Patients Infected with COVID-19 in Wuhan, China: A Single-Center Experience. Journal of Infection and Public Health, 13, 1202-1209. https://doi.org/10.1016/j.jiph.2020.07.002
[34]
Zheng, Y., Xu, H., Yang, M., Zeng, Y., Chen, H., Liu, R., et al. (2020) Epidemiological Characteristics and Clinical Features of 32 Critical and 67 Noncritical Cases of COVID-19 in Chengdu. Journal of Clinical Virology, 127, Article ID: 104366. https://doi.org/10.1016/j.jcv.2020.104366
[35]
Wu, J., Huang, J., Zhu, G., Wang, Q., Lv, Q., Huang, Y., et al. (2020) Elevation of Blood Glucose Level Predicts Worse Outcomes in Hospitalized Patients with COVID-19: A Retrospective Cohort Study. BMJ Open Diabetes Research & Care, 8, e001476. https://doi.org/10.1136/bmjdrc-2020-001476
